000 01464 a2200433 4500
005 20250515161723.0
264 0 _c20090716
008 200907s 0 0 eng d
022 _a1557-8348
024 7 _a10.1089/hyb.2008.0079
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBakhtiari, Seyed Hamid Aghaee
245 0 0 _aAnti-MUC1 nanobody can redirect T-body cytotoxic effector function.
_h[electronic resource]
260 _bHybridoma (2005)
_cApr 2009
300 _a85-92 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntibodies
_ximmunology
650 0 4 _aApoptosis
_ximmunology
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
650 0 4 _aDNA Primers
_xgenetics
650 0 4 _aGenetic Vectors
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aMucin-1
_ximmunology
650 0 4 _aNanoparticles
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aReceptors, Antigen, T-Cell
_xgenetics
650 0 4 _aRecombinant Fusion Proteins
_xgenetics
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aTransfection
700 1 _aRahbarizadeh, Fatemeh
700 1 _aHasannia, Sadegh
700 1 _aAhmadvand, Davoud
700 1 _aIri-Sofla, Farnoush Jafari
700 1 _aRasaee, Mohammad Javad
773 0 _tHybridoma (2005)
_gvol. 28
_gno. 2
_gp. 85-92
856 4 0 _uhttps://doi.org/10.1089/hyb.2008.0079
_zAvailable from publisher's website
999 _c18691291
_d18691291